• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Anika Therapeutics Inc

+ Add to Watchlist


49.7500 USD 1.8800 3.93%

As of 20:10:00 ET on 07/30/2014.

Snapshot for Anika Therapeutics Inc (ANIK)

Open: 48.5700 Day's Range: 48.1300 - 49.8100 Volume: 419,172
Previous Close: 47.8700 52wk Range: 19.9400 - 52.4900 1-Yr Rtn: +147.39%

Stock Chart for ANIK

No chart data available.
  • ANIK:US 49.6200
  • 1D
  • 1M
  • 1Y
Interactive ANIK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ANIK

Current P/E Ratio (ttm) 21.2770
Estimated P/E(12/2014) 21.4440
Relative P/E vs. SPX 1.1836
Earnings Per Share (USD) (ttm) 2.3382
Est. EPS (USD) (12/2014) 2.3200
Est. PEG Ratio 0.7148
Market Cap (M USD) 717.47
Shares Outstanding (M) 14.42
30 Day Average Volume 278,568
Price/Book (mrq) 4.5335
Price/Sale (ttm) 7.1818
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ANIK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ANIK

Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products and devices. The Company's products, based on hyaluronic acid, promote the repair, protection, and healing of bone, cartilage, and soft tissue. Anika's products include ORTHOVISC and HYVISC which treat osteoarthritis.

Charles H SherwoodPresident/CEOSylvia CheungCFO/Treasurer/Secretary
Carol A BarnettChief Commercial OfficerJohn W Sheets JrChief Scientific Officer
More Company Profile & Key Executives for ANIK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil